Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno DrugsDHA:TECHNODRUG -2.27%37 OCF Margin % is 11.12% as of Mar. 2026, which is 28% above its 10-year median of 8.72. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 10 warning signs investors should review. Among 963 Drug Manufacturers companies, Techno Drugs ranks worse than 57.22% on this metric.
The historical rank and industry rank for Techno Drugs's OCF Margin % or its related term are showing as below:
DHA:TECHNODRUG'
s OCF Margin % Range Over the Past 10 Years
Min: 5.6 Med: 8.72 Max: 11.84
Current: 6.91
During the past 2 years, the highest OCF Margin % of Techno Drugs was 11.84%. The lowest was 5.60%. And the median was 8.72%.
DHA:TECHNODRUG's OCF Margin % is ranked worse than 57.22% of 963
companies
in the Drug Manufacturers industry
Industry Median: 10.04
vs DHA:TECHNODRUG: 6.91
Techno Drugs OCF Margin % Related Terms
Techno Drugs OCF Margin % Historical Data
* Premium members only.
The historical data trend for Techno Drugs's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:TECHNODRUG vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Techno Drugs's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Drugs OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Techno Drugs's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Techno Drugs's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Drugs (DHA:TECHNODRUG) has a OCF Margin % of 11.12% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Techno Drugs and its competitors. This is 28% above median its historical median of 8.72. Over the past decade, Techno Drugs' OCF Margin % has ranged from 5.60 to 11.84. According to the industry distribution chart, Techno Drugs ranks #551 out of 963 companies in the Drug Manufacturers industry, placing it in the top 57.2%.
Is Techno Drugs' OCF Margin % too high?
Techno Drugs' current OCF Margin % of 11.12% is 28% above median its 10-year median of 8.72. Over the past 10 years, this metric has ranged from a low of 5.60 to a high of 11.84. The Drug Manufacturers industry median OCF Margin % is 10.04. Techno Drugs' value of 11.12% is 10.8% above this industry median. Based on the distribution chart, Techno Drugs ranks #551 out of 963 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Techno Drugs ranks #551 out of 963 companies for OCF Margin %. This places Techno Drugs in the lower half of its industry. The industry median OCF Margin % is 10.04. Techno Drugs' value of 11.12% is 10.8% above this benchmark. Historically, Techno Drugs' own OCF Margin % has ranged from 5.60 to 11.84 over the past decade. While the company's 10-year median is 8.72 vs. the industry median of 10.04, Techno Drugs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Drugs's current OCF Margin % of 11.12% is 10.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Techno Drugs and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Drugs's current OCF Margin % is 11.12%, which is 28% above median its own 10-year median of 8.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current OCF Margin % of 11.12%. The current OCF Margin % is 11.12%, which is 28% above median its 10-year median of 8.72 and 10.8% above the Drug Manufacturers industry median of 10.04. Techno Drugs' overall GF Score™ is 37/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current OCF Margin % is 11.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score
Get the complete analysis for DHA:TECHNODRUG
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:TECHNODRUG has been successfully added to your 
